Scottish Neurological Research Fund Announcement

 

Earlier this year, the Scottish Neurological Research Fund (SNRF) launched a second round of funding, following its success in 2019.

The scheme provides up to £15,000 of funding per application for small innovative projects investigating the cause, prevention, treatment and/or management of neurodegenerative or neurodevelopmental disorders. To encourage the development of collaborative networks, all projects need to involve at least 2 academic centres.

The SNRF is financially supported by RS Macdonald, the Chief Scientist Office and administered by the University of St Andrews

The quality of applications was extremely high, and we are delighted to announce the successful recipients of this award. The portfolio of research includes basic science, clinical and qualitative approaches aimed at better understanding conditions including Parkinson’s, Motor Neurone Disease and Alzheimer’s Disease. Please see the full list and projects below:

Name

Institution

Project Title

Aneesha Sil

University of Aberdeen

Do iron-oxide nanoparticles contribute to Parkinson’s Disease pathology?

Martin Taylor-Rowan

University of Glasgow

 

Exploring the association between physical frailty, brain frailty and long-term cognition

Sarah Gregory

University of Edinburgh

Cortisol mediated cardiovascular risk factors for dementia and other neurological conditions

Matthew Broadhead

University of St Andrews

 

Investigating Synaptic Dysfunction & TDP43

Pathology in Amyotrophic Lateral Sclerosis

Using a Synaptosome Imaging Assay

Helena Chaytow

University of Edinburgh

Repurposing terazosin for ALS: how treatment changes the proteome in a TDP-43 mouse model

Aileen Wong

Glasgow Caledonian University

Effects of a TSPO ligand on cholesterol homeostasis in an Alzheimer’s disease mouse model

Mizuki Morisaki

University of St Andrews

Alpha-amylase: a potential therapeutic target for Alzheimer’s Disease

Stina Saunders

University of Edinburgh

Development of the electronic Person Specific Outcome measure (ePSOM) app: A technological solution for an outcome measure used in the Alzheimer’s disease trials and practice

Eileen Harkness-Murphy

Alzheimer Scotland Centre for Policy and Practice, University of the West of Scotland (UWS)

 

Trauma Informed Approach in Dementia (TrIAD): Understanding trauma within family based dementia care: an analysis of Telephone Helpline Calls

 

 

 

Congratulations to all the researchers who received awards. We look forward to following on with your progress. 

If you are a researcher, you can keep up to date with all the latest funding and career opportunities in Scotland here. Also make sure to follow the SDRC on Twitter. 

 

 

Read more SDRC Latest

Ten years of the Alzheimer Scotland Dementia Research Centre: past, present, and future

Alzheimer Scotland Dementia Research Centre (ASDRC) is in partnership with the University of Edinburgh and provides a high quality environment for dementia research. On the 21st September 2021, the ASDRC celebrated its 10th Anniversary. To celebrate this, they...

SDRC Executive Committee Member: Dr Jennifer Macfarlane

In October 2022, the SDRC held our election to refresh the Executive Committee. We are now able to announce who was successfully voted. Jennifer Macfarlane has been a co-opted member of the SDRC Executive Committee since earlier this year, we are now delighted to...

New SDRC Executive Committee Member: Dr Leah Macaden

Following the 2022 SDRC Executive Committee election, Dr Leah Macaden has been elected as a new member. Find out more in Leah's biography below. Dr Leah Macaden is a Senior Lecturer in Nursing at the University of Edinburgh with a rich and diverse range of academic,...

Life Sciences Event with the SDRC, SULSA, Brain Health Scotland & Alzheimer Scotland

On the 26-27 May 2022, the Scottish Universities Life Sciences Alliance (SULSA), the Scottish Dementia Research Consortium, Brain Health Scotland and Alzheimer Scotland hosted world leaders in Life Sciences at a summit at the University of St Andrews.  This two-day...

SDRC Virtual Conference 2020 Summary

On the 7th September 2020, the SDRC hosted our fifth annual conference. The Conference was our biggest event yet. Over 240 people registered to attend, with three plenary speakers, eight early career researchers, 15 poster exhibitors and four exhibition stands. Thank...

New SDRC Executive Committee Member: Stina Saunders

Our final announcement of new SDRC Executive Committee members is Stina Saunders. We are delighted to have Stina joining us and look forward to working with her and all the new members. Find out more about Stina in the blog below.   I am in the final year of my PhD at...

The launch of the SDRC Annual Report 2022/23

The SDRC Annual Report 2023, launched at the SDRC Annual Conference on Tuesday 25th April 2023. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. It includes the updates from each of the SDRC Research...

Treating dementia, what’s next and how do we get there?

On the 21st September 2021, World Alzheimer's Day, Alzheimer Scotland held their annual conference. It was a virtual event which was attended by people with dementia, carers, practitioners and other members of the public from all over Scotland.  In the afternoon...

Take part in a research study: Remote Cognitive Testing Survey

The University of Oxford are looking for volunteers from Scotland to take part in a survey about the Impact of COVID-19 on cognitive testing  The Translational Neuropsychology Lab at the University of Oxford, are investigating the impacts of COVID-19 UK lockdown on...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...